Villich News

Clinicians urged to consider spironolactone in HFPEF despite TOPCAT results


ScienceDaily - 18-May-2014

Clinicians have been urged to consider using spironolactone in their patients with heart failure and preserved ejection fraction (HFPEF) after a post-hoc analysis of the TOPCAT trial showed benefit in patients from the Americas. TOPCAT randomized 3445 patients with HFPEF to receive spironolactone, a mineralocorticoid receptor antagonist, at a dose of 15-45mg per day or placebo on top of usual care....


Read full article at ScienceDaily


The Wall Street Journal - 26-Sep-2014

The craft of opposition research—finding information that might put an opponent in a negative light—has long been a staple of political campaigns. This year, independent groups are taking a leading role....

The Wall Street Journal - 26-Sep-2014

Cynthia Quarterman, a top U.S. safety regulator tasked with handling the U.S. government's response to a string of oil-train crashes in recent years, is stepping down....

The Wall Street Journal - 26-Sep-2014

The U.S. government will pay the Navajo Nation $554 million to settle long-standing claims that it mismanaged funds and natural resources on the tribe's reservation for years....

The Wall Street Journal - 26-Sep-2014

Connecticut gubernatorial candidate Joe Visconti opposes the state's new gun restrictions, and he has an online commercial that shows him riding in a 1974 Pontiac convertible with rifles fixed to the rear fenders. ...

The Wall Street Journal - 26-Sep-2014

The U.S. and Arab allies launched a second major wave of airstrikes in Syria targeting mobile oil refineries controlled by Islamic State, the Pentagon said....

0,3,4,5,6,7,8

Villich Login
 
Username:

Password:
Remember login